Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Marco Bortolato
Based on 6 articles published since 2008
||||
Expertise Level
The expertise of Marco Bortolato ranks in the
  • Top 2.8%
  • ... of 69,482 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2019
  • ... based on contributions to 6 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    University of Utah   Contact    
2017
  • Dept. of Biomedical Sciences, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. · Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Piazza del Mercato, 15, 25121 Brescia, Italy. · Movement Disorders Center, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, 30 S 2000 E, Salt Lake City, UT 84112, USA. · Dept. of Biomedical Sciences, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. Electronic address: · Pubmed 28131725
  • Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States. · Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States; Dept. of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Electronic address: · Pubmed 27889491
Probable:    University of Kansas Lawrence      
2017
  • Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States. · Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States; Dept. of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Electronic address: · Pubmed 27889491
Probable:    University of Cagliari      
2010
  • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Cagliari, Italy. · Pubmed 20386102
2015
  • Movement Disorders Center, Department of Neurology, Institute of Neurology, University of Cagliari, Cagliari, Italy. · Pubmed 25759330
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Marco Bortolato in 2008-2019 about Parkinson Disease:

  • The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. 2017
  • Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release. 2017
  • Paraphilias and paraphilic disorders in Parkinson's disease: A systematic review of the literature. 2015
  • Finasteride attenuates pathological gambling in patients with Parkinson disease. 2012
  • Treatment of benign essential blepharospasm with finasteride: a case report. 2010
  • Monoamine oxidase inactivation: from pathophysiology to therapeutics. 2008
Show List of Full Article Records
Google Searches

Learn more about Marco Bortolato using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Utah
University of Kansas Lawrence
University of Cagliari
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Utah
2017
  • Dept. of Biomedical Sciences, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. · Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Piazza del Mercato, 15, 25121 Brescia, Italy. · Movement Disorders Center, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, 30 S 2000 E, Salt Lake City, UT 84112, USA. · Dept. of Biomedical Sciences, University of Cagliari, Cittadella Universitaria SP 8, Monserrato 09042, Italy. Electronic address: · Pubmed 28131725
  • Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States. · Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States; Dept. of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Electronic address: · Pubmed 27889491
University of Kansas Lawrence
2017
  • Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. · Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Applied Behavioral Science, University of Kansas, Lawrence, KS, United States. · Dept. of Biomedical Sciences, Neuroscience Division, University of Cagliari, Italy. · Dept. of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States. · Dept. of Pharmacology, University of Washington, Seattle, WA, United States; Dept. of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States. · Dept. of Pharmacology and Toxicology, University of Kansas, Lawrence, KS, United States; Problem Gambling Research Studies (ProGResS) Network, University of Kansas, Lawrence, KS, United States; Dept. of Pharmacology and Toxicology, College of Pharmacy, University of Utah, Salt Lake City, UT, United States. Electronic address: · Pubmed 27889491
University of Cagliari
2010
  • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Cagliari, Italy. · Pubmed 20386102
2015
  • Movement Disorders Center, Department of Neurology, Institute of Neurology, University of Cagliari, Cagliari, Italy. · Pubmed 25759330
University of Southern California
2010
  • Department of Neurological and Cardiovascular Sciences, University of Cagliari, Cagliari, Italy. · Pubmed 20386102
2008
  • Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA. · Pubmed 18652859
Yearly article counts 002010010101
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.